Associate Lindsey Gabrielsen is quoted in a
New York Times article, “
Administration Imposes Sweeping Limits on Federal Actions Against Companies,” about the ramifications of the Justice Department’s adoption of new limits on the use of ‘guidance documents” by federal agencies.
In view of the new policy, Gabrielsen said, the government “will face serious hurdles” in enforcement actions based on violations of health care guidance documents.
Gabrielsen’s comments to the
New York Times were also republished in
Esquire,
FierceHealthcare and
MSN.